Production (Stage)
Amneal Pharmaceuticals, Inc.
AMRX
$7.16
-$0.03-0.42%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 61.63M | 112.42M | 77.26M | 47.22M | 48.46M |
| Total Receivables | 800.29M | 808.56M | 786.23M | 803.38M | 704.05M |
| Inventory | 601.43M | 612.45M | 596.36M | 575.62M | 570.65M |
| Prepaid Expenses | 40.52M | 46.50M | 49.11M | 53.41M | 51.79M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 6.58M | 7.87M | 4.34M | 5.85M | 5.10M |
| Total Current Assets | 1.51B | 1.59B | 1.51B | 1.49B | 1.38B |
|
|
|||||
| Total Current Assets | 1.51B | 1.59B | 1.51B | 1.49B | 1.38B |
| Net Property, Plant & Equipment | 522.75M | 523.69M | 532.90M | 528.94M | 544.79M |
| Long-term Investments | 597.50M | 597.44M | 598.32M | 598.53M | 598.55M |
| Goodwill | 597.50M | 597.44M | 598.32M | 598.53M | 598.55M |
| Total Other Intangibles | 689.14M | 732.38M | 780.19M | 819.94M | 859.27M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 21.65M | 24.21M | 18.34M | 24.57M | 21.12M |
| Total Assets | 3.37B | 3.50B | 3.46B | 3.51B | 3.46B |
|
|
|||||
| Total Accounts Payable | 194.07M | 259.84M | 236.92M | 201.78M | 176.98M |
| Total Accrued Expenses | 263.30M | 307.31M | 279.18M | 268.37M | 238.19M |
| Short-term Debt | 290.00M | 100.00M | 140.00M | 179.00M | 179.00M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 47.54M | 240.26M | 241.02M | 272.65M | 49.67M |
| Total Finance Division Other Current Liabilities | 280.91M | 222.36M | 198.08M | 192.56M | 190.56M |
| Total Other Current Liabilities | 280.91M | 222.36M | 198.08M | 192.56M | 190.56M |
| Total Current Liabilities | 1.08B | 1.13B | 1.10B | 1.11B | 834.39M |
|
|
|||||
| Total Current Liabilities | 1.08B | 1.13B | 1.10B | 1.11B | 834.39M |
| Long-Term Debt | 2.15B | 2.16B | 2.17B | 2.18B | 2.42B |
| Short-term Debt | 290.00M | 100.00M | 140.00M | 179.00M | 179.00M |
| Capital Leases | 87.98M | 91.09M | 94.03M | 95.92M | 97.56M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 106.86M | 163.33M | 135.81M | 126.14M | 121.45M |
| Total Liabilities | 3.42B | 3.55B | 3.49B | 3.51B | 3.47B |
|
|
|||||
| Common Stock & APIC | 548.94M | 563.31M | 556.33M | 548.80M | 541.81M |
| Retained Earnings | -594.87M | -607.06M | -575.98M | -575.83M | -581.82M |
| Treasury Stock & Other | -85.74M | -65.51M | -73.78M | -30.44M | -23.71M |
| Total Common Equity | -131.67M | -109.27M | -93.43M | -57.47M | -63.72M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -131.67M | -109.27M | -93.43M | -57.47M | -63.72M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 72.28M | 64.73M | 59.75M | 53.40M | 47.12M |
| Total Equity | -59.39M | -44.54M | -33.68M | -4.07M | -16.61M |
|
|
|||||